Literature DB >> 8739511

Post-abortion complications after interruption of pregnancy with misoprostol.

A Faúndes1, L C Santos, M Carvalho, C Gras.   

Abstract

The high incidence of abortion in Brazil and the increased use of misoprostol among women having clandestine/unsafe abortions has led to an interest in evaluating whether there is an association between the use of misoprostol and the incidence of septic complications post-abortion. To test this association, a retrospective cohort study was conducted with 1840 women treated post-abortion at the Instituto Materno-Infantil de Pernambuco (IMIP) between 1988 and 1992. Incidence of infection (4.2%) was lower in women stating they had used misoprostol than in those stating that the abortion was not induced (7.9%) and twelve times lower than in women stating that they had used other methods (49.4%). These results suggest that misoprostol is a safe, inexpensive method for inducing abortion, and leads to fewer complications and consequently shorter hospital stays. Misoprostol should be considered a viable option in situations where induction of abortion is legal or medically indicated.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8739511     DOI: 10.1007/bf01849540

Source DB:  PubMed          Journal:  Adv Contracept        ISSN: 0267-4874


  11 in total

1.  Inequalities in access to and quality of abortion services in Mexico: Can task-sharing be an opportunity to increase legal and safe abortion care?

Authors:  Raffaela Schiavon; Erika Troncoso
Journal:  Int J Gynaecol Obstet       Date:  2020-07       Impact factor: 3.561

2.  Perceptions and practices of illegal abortion among urban young adults in the Philippines: a qualitative study.

Authors:  Jessica D Gipson; Alanna E Hirz; Josephine L Avila
Journal:  Stud Fam Plann       Date:  2011-12

3.  The public health threat of anti-abortion legislation.

Authors:  Daniel Grossman; Kari White; Kristine Hopkins; Joseph E Potter
Journal:  Contraception       Date:  2013-11-04       Impact factor: 3.375

4.  A harm-reduction model of abortion counseling about misoprostol use in Peru with telephone and in-person follow-up: A cohort study.

Authors:  Daniel Grossman; Sarah E Baum; Denitza Andjelic; Carrie Tatum; Guadalupe Torres; Liza Fuentes; Jennifer Friedman
Journal:  PLoS One       Date:  2018-01-10       Impact factor: 3.240

5.  Medical Abortion Provision by Pharmacies and Drug Sellers in Low- and Middle-Income Countries: A Systematic Review.

Authors:  Katharine Footman; Katherine Keenan; Kate Reiss; Barbara Reichwein; Pritha Biswas; Kathryn Church
Journal:  Stud Fam Plann       Date:  2018-03

6.  Measurement of abortion safety using community-based surveys: Findings from three countries.

Authors:  Suzanne O Bell; Funmilola OlaOlorun; Mridula Shankar; Danish Ahmad; Georges Guiella; Elizabeth Omoluabi; Anoop Khanna; Andoh Kouakou Hyacinthe; Caroline Moreau
Journal:  PLoS One       Date:  2019-11-07       Impact factor: 3.240

Review 7.  Latin American women's experiences with medical abortion in settings where abortion is legally restricted.

Authors:  Nina Zamberlin; Mariana Romero; Silvina Ramos
Journal:  Reprod Health       Date:  2012-12-22       Impact factor: 3.223

8.  Incidence and determinants of severe maternal morbidity: a transversal study in a referral hospital in Teresina, Piaui, Brazil.

Authors:  Alberto Pereira Madeiro; Andréa Cronemberger Rufino; Érica Zânia Gonçalves Lacerda; Laís Gonçalves Brasil
Journal:  BMC Pregnancy Childbirth       Date:  2015-09-07       Impact factor: 3.007

9.  Realising the right to sexual and reproductive health: access to essential medicines for medical abortion as a core obligation.

Authors:  Katrina Perehudoff; Lucía Berro Pizzarossa; Jelle Stekelenburg
Journal:  BMC Int Health Hum Rights       Date:  2018-02-01

10.  Estimating the incidence of abortion: using the Abortion Incidence Complications Methodology in Ghana, 2017.

Authors:  Chelsea B Polis; Philicia W Castillo; Easmon Otupiri; Sarah C Keogh; Rubina Hussain; Emmanuel K Nakua; Roderick Larsen-Reindorf; Suzanne O Bell
Journal:  BMJ Glob Health       Date:  2020-04-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.